Article
A case report of biotin-thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?
Medicine - 1 Oct 2016
Aljabri Mohammad F, Kamal Naglaa M, Arif Moinuddin, AlQaedi Asrar M, Santali Enas Y M
Abstract excerpt
BACKGROUND: Biotin-thiamine-responsive basal ganglia disease (BTRBGD) is a neurometabolic autosomal recessive (AR) disorder characterized by subacute encephalopathy with confusion, convulsions, dysarthria, and dystonia. The disease is completely reversible if treated early with biotin and thiamine, and can be fatal if left untreated.We herein present our experience with in an extended family study of an index...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
